Abstract:Eight genes encoding for subunits of four distinct metabolic enzymes (IDH1, IDH2, SDH and FH) are mutated in various types of human malignancies. Of these 8 genes, IDH1 is the most frequently mutated, in particular in low-grade gliomas. Oncogenic mutation in IDH1 and IDH2 abolish their normal catalytic activity in producing α-ketoglutarate (αKG) and also gain a new function to produce oncometabolite D-2-hydroxyglutarate (D2HG). We previously discovered that D2HG, and its enantiomer, L2HG, act a competitive inhibitor of αKG and inhibit both αKG- dependent JmiC family of histone demethylases and TET family of DNA demethylases. These discoveries provide a molecular basis for the CpG island methylator phenotype (CIMP) observed in IDH-mutant gliomas. More recently, we demonstrated that D2HG also inhibits αKG- dependent alkB homolog (ALKBH) family of DNA repair enzymes, sensitizing IDH1-mutant glioma cells to alkylating agents such as methyl methanesulfonate (MMS), N-methyl-N0- nitro-N-nitrosoguanidine (MNNG) and CCNU/lomustine. These results provide a molecular basis for the clinical benefits seen in IDH-mutant glioma patients who in addition to radiation therapy (RT) received a chemotherapy of procarbazine, CCNU/lomustine, and vincristine (PCV). These results also suggest that impairment of DNA repair may contribute to tumorigenesis driven by IDH mutations and that alkylating agents may merit exploration for treating IDH-mutated cancer patients. Accumulation of D2HG and L2HG are also found in rare neurometabolic disorders and brain tumors, known as 2-hydroxyglutaric aciduria. They are caused by mutations targeting genes encoding for either D2HG or L2HG dehydrogenase (D2HGDH and L2HGDH), respectively, that clean up both enantiomers of 2HG. To determine the biochemical and pathophysiological consequences of L2HG accumulation, we created L2hgdh knockout (KO) mice. L2hgdh null mice exhibited a robust increase of L2HG in multiple tissues. The highest L2HG is observed in brain and testis with corresponding increase of histone methylation in these tissues. L2hgdh KO mice exhibit white matter abnormalities, extensive gliosis, microglia-mediated neuroinflammation, and an expansion of oligodendrocyte progenitor cells (OPCs). Moreover, L2hgdh deficiency leads to impaired adult hippocampal neurogenesis and late-onset neurodegeneration in mouse brains. These observations provide in vivo evidence to support that L2hgdh mutation leads to L2HG accumulation, leukoencephalopathy, and neurodegeneration in mice, thus offering new insights into the pathophysiology of L2HGA and IDH-mutant glioma in human. We will also discuss our recent progress in characterizing the function and regulation of additional αKG-antagonizing oncometabolites in the epigenetic control and oncogenesis.

L2hgdh Deficiency Accumulates L-2-hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

Correction for Li and Guan, “human Mitochondrial Leucyl-tRNA Synthetase Corrects Mitochondrial Dysfunctions Due to the Trnaleu(uur) A3243G Mutation, Associated with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Symptoms and Diabetes”

Loss of the mitochondrial citrate carrier, disrupts embryogenesis 2-Hydroxyglutarate

P08.65 the Mechanisms of Oncometabolites in Epigenetic Control, DNA Repair, Neural Development and Gliomagenesis

Late-onset cerebellar ataxia and a new frameshift L2HGDH mutation in a Chinese adult with L-2-hydroxyglutaric aciduria: a case report

L-2-hydroxyglutaric aciduria: a report of clinical, radiological, and genetic characteristics of two siblings from Egypt

GUCY2D Gene Loss-of-Function Mutations Responsible for Leber Congenital Amaurosis 1

The broad spectrum of clinical manifestations observed in three patients with L2 hydroxyglutaric aciduria spans from febrile seizures to complex dystonia

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene

Early-Onset Parkinson's Disease Caused by PLA2G6 Compound Heterozygous Mutation, a Case Report and Literature Review

Focal dystonia in an adult with L-2- hydroxyglutaric aciduria

1581-P: Systemic Alteration of Amino Acids Metabolism in Glutamate Dehydrogenase Gain-of-Function Mutation Knockin Mice

Structure, substrate specificity, and catalytic mechanism of human D-2-HGDH and insights into pathogenicity of disease-associated mutations

The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase

[Clinical and Genetic Analysis of a Family with Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation].

Brain [U-13 C]glucose metabolism in mice with decreased α-ketoglutarate dehydrogenase complex activity

Lactate Dehydrogenase C Produces S-2-Hydroxyglutarate in Mouse Testis

Impaired novelty acquisition and synaptic plasticity in congenital hyperammonemia caused by hepatic glutamine synthetase deficiency

A novel <i>Lgi1</i> mutation causes white matter abnormalities and impairs motor coordination in mice

Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement